Comparison

Research To Practice vs HemeOncBuddy

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Research To Practice

Access CME/CNE accredited oncology education with diverse content formats. Stay updated on cancer research and management strategies through audio, video, and slide presentations. Content is organized by tumor type and recent releases.

Highlights
  • CME/CNE accredited activities
  • Sort by tumor type or recent releases
  • Audio, video, and slide formats
  • Dr Love's Picks
  • Upcoming events
  • Free content
Features
Read full description

Research To Practice’s CME/CNE accredited activities provide comprehensive perspectives on emerging cancer research and practical management strategies for practicing oncology clinicians. Featuring audio, video and slide-based formats edited by Dr Neil Love, RTP’s programs bridge the gap between clinical research and patient care. Key Features: - Sort educational activities by recent releases or by tumor type - View “Dr Love’s Picks” - Listen to audio or read text excerpts* - Watch webcasts, symposia proceedings and investigator presentations - Review slide sets - View upcoming events moderated by Dr Love - CME and CNE accredited - All content is free * Text not available on all programs

About

HemeOncBuddy

This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.

Highlights
  • Practice-changing clinical trial summaries
  • Hematology and Oncology focus
  • Simplified trial information
  • Inclusion and exclusion criteria
  • Primary endpoints and outcomes
  • Quick reference tool
Features
Read full description

HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app. WHAT'S INSIDE - 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly. - A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking. - ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks. - 120+ concise disease-site board-prep notes. - A conference & abstract-deadline tracker so you never miss a submission window. MADE FOR STUDYING - Full dark mode and adjustable text size. - Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac. - No ads. No paywall. No login required to browse. HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.

Screenshots

Research To Practice4 screens
HemeOncBuddy4 screens

Verdict

The call

The clearest difference is ads: HemeOncBuddy at none against Research To Practice's shown. HemeOncBuddy also leads on rating (5.0 vs 4.8) and monetization model (free vs ad-supported). Research To Practice's advantage is update cadence (every 5 months vs every 24 months). On price, review sentiment, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

HemeOncBuddy holds the better App Store score, 5.0 against 4.8. Both are backed by a comparable volume of ratings — 4 and 19 respectively. Written reviews split almost evenly too, at 100% and 100% positive.

UpkeepUpdate frequency

Research To Practice ships an update every 5 months, HemeOncBuddy every 24 months. The most recent releases landed on November 1, 2026 and November 7, 2026 respectively.

Scorecard6 real differences · 4 level
Research To Practice versus HemeOncBuddy: the parameters behind the verdict, then further details
ParameterResearch To PracticeHemeOncBuddy
PriceFreeFree
Rating4.8 (4 ratings)5.0 (19 ratings) — better
Positive reviews100.0% of reviews100.0% of reviews
Number of ratings419 — better
Update frequencyEvery 5 months — betterEvery 24 months
AdsYesNo — better
In-app purchasesNoNo
MonetizationAd-supportedFree — better
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS17.015.0 — better
Further details — not scored
Size53 MB16 MB
Age rating17+17+
DeveloperResearch To PracticeVeli Bakalov

Customer experience

Research To Practice

All ratings4 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews3 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

HemeOncBuddy

All ratings17 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews2 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

Research To Practice

No in-app purchases

None

HemeOncBuddy

No in-app purchases

Questions

Is Research To Practice free?
Research To Practice is free to download, with no in-app purchases.
Is HemeOncBuddy free?
HemeOncBuddy is free to download, with no in-app purchases.
Which has better reviews, Research To Practice or HemeOncBuddy?
HemeOncBuddy is rated higher. Research To Practice averages 4.8 out of 5 from 4 ratings, while HemeOncBuddy averages 5.0 from 19 ratings.
Do Research To Practice or HemeOncBuddy have ads?
Research To Practice shows ads; HemeOncBuddy does not.
Which is updated more often, Research To Practice or HemeOncBuddy?
Research To Practice ships an update every 5 months, and HemeOncBuddy every 24 months. Most recently, Research To Practice was updated on November 1, 2026 and HemeOncBuddy on November 7, 2026.

Other comparisons